# FDA Inspection 1060487 - Baxter Deutschland GmbH - June 14, 2018

Source: https://www.keypedia.com/records/fda_inspections/baxter-deutschland-gmbh/4091a99f-a1cd-45dd-9ab6-0dfc83ac165f
Source feed: FDA_Inspections

> FDA Inspection 1060487 for Baxter Deutschland GmbH on June 14, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1060487
- Company Name: Baxter Deutschland GmbH
- Inspection Date: 2018-06-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1288760 - 2025-05-28](https://www.keypedia.com/records/fda_inspections/baxter-deutschland-gmbh/45f2f1c1-6c8b-473c-812e-287082678a2b)
- [FDA Inspection 1288760 - 2025-05-28](https://www.keypedia.com/records/fda_inspections/baxter-deutschland-gmbh/ab2bc592-2030-4c1b-9bea-829ff0a34dbd)
- [FDA Inspection 1193847 - 2022-11-11](https://www.keypedia.com/records/fda_inspections/baxter-deutschland-gmbh/3a7b7a03-3f8a-45ee-a1e1-ad8c1db5f380)
- [FDA Inspection 957912 - 2016-01-22](https://www.keypedia.com/records/fda_inspections/baxter-deutschland-gmbh/4c49d6f4-9d46-4906-84d0-2857d01df144)
- [FDA Inspection 746997 - 2011-08-26](https://www.keypedia.com/records/fda_inspections/baxter-deutschland-gmbh/bbd74af3-f78f-4a21-8a9c-43ac1978058f)

Company: https://www.keypedia.com/companies/baxter-deutschland-gmbh/91ec8f78-8f1e-4966-bd89-d4e4aaf6eb76

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c